CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoCECCHI, Irene
Dettaglio
CECCHI, Irene
SCIENZE CLINICHE E BIOLOGICHE
Pubblicazioni
Risultati 1 - 20 di 50 (tempo di esecuzione: 0.0 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | 16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome | 2021 | Sciascia S.; Radin M.; Cecchi I.; Levy R.A.; Erkan D. |
| 2 | A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response | 2021 | Rossi, Daniela; Sciascia, Savino; Cecchi, Irene; Saracco, Marta; Montabone, Erika; Modena, Vittorio; Pellerito, Raffaele; Carignola, Renato; Roccatello, Dario |
| 3 | An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis | 2021 | Rossi, Daniela; Cecchi, Irene; Sciascia, Savino; Naretto, Carla; Alpa, Mirella; Roccatello, Dario |
| 4 | Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis | 2020 | Sciascia S.; Radin M.; Cecchi I.; Fenoglio R.; De Marchi A.; Besso L.; Baldovino S.; Rossi D.; Miraglia P.; Rubini E.; Roccatello D. |
| 5 | Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab | 2018 | Sciascia, Savino*; Rubini, Elena; Radin, Massimo; Cecchi, Irene; Rossi, Daniela; Roccatello, Dario |
| 6 | Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome | 2020 | Radin M.; Foddai S.G.; Cecchi I.; Rubini E.; Schreiber K.; Roccatello D.; Bertolaccini M.L.; Sciascia S. |
| 7 | Antiphospholipid antibodies negativization: Time for testing for non-criteria aPL? | 2017 | Radin M.; Cecchi I.; Perez-Sanchez C. |
| 8 | Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al | 2020 | Radin M.; Sciascia S.; Bazzan M.; Bertero T.; Carignola R.; Montabone E.; Montaruli B.; Vaccarino A.; Cecchi I.; Rubini E.; Roccatello D.; Baldovino S. |
| 9 | ASIA Syndrome Following Breast Implant Placement | 2018 | Fenoglio, Roberta; Cecchi, Irene; Roccatello, Dario |
| 10 | Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies | 2021 | Radin M.; Barinotti A.; Foddai S.G.; Cecchi I.; Rubini E.; Roccatello D.; Menegatti E.; Sciascia S. |
| 11 | Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome | 2018 | Perez-Sanchez C.; Arias-de la Rosa I.; Aguirre M.A.; Luque-Tevar M.; Ruiz-Limon P.; Barbarroja N.; Jimenez-Gomez Y.; Abalos-Aguilera M.C.; Collantes-Estevez E.; Segui P.; Velasco F.; Herranz M.T.; Lozano-Herrero J.; Hernandez-Vidal M.J.; Martinez C.; Gonzalez-Conejero R.; Radin M.; Sciascia S.; Cecchi I.; Cuadrado M.J.; Lopez-Pedrera C. |
| 12 | Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients | 2020 | Cecchi I.; Perez-Sanchez C.; Sciascia S.; Radin M.; Arias de la Rosa I.; Barbarroja Puerto N.; Scudeler L.; Perez-Sanchez L.; Patino Trives A.M.; Aguirre Zamorano M.A.; Menegatti E.; Roccatello D.; Lopez-Pedrera C. |
| 13 | Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss | 2021 | Cecchi I.; Radin M.; Rubini E.; Foddai S.G.; Barinotti A.; Roccatello D.; Sciascia S. |
| 14 | Clinical utility of the global anti-phospholipid syndrome score for risk stratification: A pooled analysis | 2018 | Sciascia, Savino; Radin, Massimo; Sanna, Giovanni; Cecchi, Irene; Roccatello, Dario; Bertolaccini, Maria Laura |
| 15 | Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients | 2021 | Radin, Massimo; Rubini, Elena; Cecchi, Irene; Foddai, Silvia Grazietta; Barinotti, Alice; Rossi, Daniela; Sciascia, Savino; Roccatello, Dario |
| 16 | Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion | 2019 | Perez-Sanchez C.; Cecchi I.; Barbarroja N.; Patino-Trives A.M.; Luque-Tevar M.; Perez-Sanchez L.; Ibanez-Costa A.; Arias de la Rosa I.; Ortega R.; Escudero A.; Castro M.C.; Radin M.; Roccatello D.; Sciascia S.; Aguirre M.A.; Collantes E.; Lopez-Pedrera C. |
| 17 | Endothelial dysfunction and cardiovascular risk in lupus nephritis: new roles for old players? | 2021 | Mancardi, Daniele; Arrigo, Elisa; Cozzi, Martina; Cecchi, Irene; Radin, Massimo; Fenoglio, Roberta; Roccatello, Dario; Sciascia, Savino |
| 18 | Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome | 2020 | Savino Sciascia, Massimo Radin, Carlos Ramirez, Andrea Seaman, Chelsea Bentow, Silvia Casas, Irene Cecchi, Elena Rubini, Silvia Grazietta Foddai, Simone Baldovino, Roberta Fenoglio, Elisa Menegatti, Dario Roccatello, Michael Mahler |
| 19 | Genetic factors in antiphospholipid syndrome: Preliminary experience with whole exome sequencing | 2020 | Barinotti A.; Radin M.; Cecchi I.; Foddai S.G.; Rubini E.; Roccatello D.; Sciascia S.; Menegatti E. |
| 20 | The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes | 2020 | Schreiber, Karen; Radin, Massimo; Cecchi, Irene; Rubini, Elena; Roccatello, Dario; Jacobsen, Søren; Cuadrado, Maria J; Sciascia, Savino |
Copyright © 2022